Procter & Gamble vs. Colgate-Palmolive: Which Dividend Stock Is Safer?

Both consumer giants beat earnings, yet their margins are moving in opposite directions as oil prices climb and a cautious U.S. shopper holds back. One dividend carries a thin balance sheet buffer, and retirees need to know which one.

Published November 5, 2026, 1:47pm ET · 3 min read

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

A close-up photograph of multiple financial charts and graphs on white paper, held by a blue clipboard. The word 'DIVIDENDS' is printed in large, bold black letters across the center sheet. A green paperclip holds additional chart papers, and a neon yellow highlighter rests in the foreground. The charts use green and yellow bars along with orange line graphs to illustrate data points.
Financial charts and the prominent word "DIVIDENDS" underscore the importance of strategic investment in building passive income streams for long-term financial stability. © Jack_the_sparow / Shutterstock.com

Procter & Gamble (NYSE:PG | PG Price Prediction) and Colgate-Palmolive (NYSE:CL) reported eight days apart, and both beat revenue and earnings expectations. For retirees, the key question is which dividend can absorb oil-driven cost spikes, currency swings, and a hesitant U.S. shopper? The two companies answered it differently.

Shoppers Buy More P&G Products While Colgate Wins on Price

P&G posted Q1 FY2027 core EPS of $2.00, beating the $1.89 estimate. Organic sales rose 4.0%, and volume supplied 2.4 points of that gain. That points to more households buying Tide and Pampers, which is the soundest kind of growth. Pampers Amore alone is projected to exceed $100 million in first-year sales. The cost is margin: core gross margin fell 150 basis points, and management sees a $1.4 billion after-tax commodity pressure that assumes $100 Brent crude. As management put it, “The strength is real, but it won’t be a straight line.”

Colgate beat with base EPS of $0.97 against a $0.93 estimate. Pricing drove 2.0% of its 3.6% organic growth, and base gross margin expanded 90 bps to 60.3%. That margin direction runs opposite to P&G’s. North America remains a soft spot, with volume down 3.7%. CEO Noel Wallace called the U.S. fix “very much a work in progress.”

PG earnings explorer
CL earnings explorer

Dividend Lens P&G Colgate
Forward Annual Dividend $4.354 $2.12
Forward Yield 2.6% 2.1%
Latest Annual Raise 3.0% 1.9%
Consecutive Increases 70 years 63 years

Cash Coverage Exposes a Balance Sheet Gap

P&G’s forward dividend equals roughly 62% of its $7.00 core EPS guidance midpoint. That leaves comfortable room. FY2026 free cash flow of $15.84B covers the planned $10B-plus in dividends, with buybacks absorbing most of the rest.

Colgate grew free cash flow 7%, yet shareholders’ equity fell to $288M after years of repurchases. I see that thin buffer as a real constraint. Currency adds risk too: FX lifted Latin America sales by 6.5%, but Brazil’s real has since turned against the dollar.

Investors have rewarded Colgate’s margin story anyway. Its shares are up 29.3% year to date versus 21.33% for P&G.

PG price target
CL price target

Oil and U.S. Market Share Will Settle This in 2027

I’m watching whether P&G’s pricing-with-innovation approach holds as greater cost pressure arrives in the back half. Management wants more than 80% of its top U.S. customers holding or growing share by year-end. For Colgate, keep an eye on the 2027 U.S. innovation cycle. Wallace already warned, “We do not see the headwinds on commodities lightening up as we exit the year.”

Why P&G’s Dividend Looks Sturdier for Retirement Income

For income-focused investors considering these names, P&G offers a higher yield, a bigger recent raise, a longer run, and cash flow that covers the payout well even with core EPS guidance flat to slightly up. Colgate fits a dividend-growth investor who can stomach emerging-market currency swings for its expanding margins and Hill’s momentum. I would rethink my view if P&G cut guidance on oil, or if Colgate’s North American volume turned positive.

Contact [email protected] for any questions or corrections.

Chris Lange

Chris Lange is a financial and geopolitical writer with more than a decade of experience covering a myriad of topics. He has published thousands of articles for 24/7 Wall St., with past coverage focused heavily on stocks, IPOs, healthcare, defense, global affairs, and technology.

His work has been quoted, or referenced by a number of outlets including Business Insider, USA Today, Yahoo Finance, MSN, The Motley Fool, and many other publications. A graduate of Southwestern University, he studied business with a focus on investments and has previous experience in banking and startups.

When not reading or writing the news, he is following his passion for Lacrosse, playing chess, or building solar projects with his dad.

All articles →